Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training

Neurobiology of Learning and Memory

Volumn 80, Issue 2, 2003, Pages 147-157

  Gould, Thomas J ^a   Higgins, J Stephen ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Aging; Amygdala; Hippocampus; Learning; Memory

Indexed keywords

MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; AUDITORY STIMULATION; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; FEAR; LEARNING; MALE; MEMORY; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; SHOCK; TRAINING;

EID: 0042661151     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7427(03)00057-1     Document Type: Article

References (86)

1. Acri J.B., Morse D.E., Popke E.J., Grunberg N.E. Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology. 114:1994;369-374.
2. Alkondon M., Pereira E.F.R., Barbosa C.T.F., Albuquerque E.X. Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons of rat hippocampal slices. Journal of Pharmacology and Experimental Therapeutics. 283:1997;1396-1411.
3. Alkondon M., Rocha E.S., Maelicke A., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat brain. α-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. Journal of Pharmacology and Experimental Therapeutics. 278:1996;1460-1471.
4. Arendash G.W., Sanberg P.R., Sengstock G.J. Nicotine enhances the learning and memory of aged rats. Pharmacology Biochemistry And Behavior. 52:1995;517-523.
5. Arendash G.W., Sengstock G.J., Sanberg P.R., Kem W.R. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Research. 674:1995;252-259.
6. Belluardo N., Mudo G., Blum M., Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behavioural Brain Research. 113:2000;21-34.
7. Blanchard R.J., Blanchard D.C. Passive and active reactions to fear-eliciting stimuli. Journal of Comparative and Physiological Psychology. 68:1969;129-135.
8. Broide R.S., Leslie F.M. The α7 nicotinic acetylcholine receptor in neuronal plasticity. Molecular Neurobiology. 20:1999;1-16.
9. Brown R.W., Gonzalez C.L., Kolb B. Nicotine improves Morris water task performance in rats given medial frontal cortex lesions. Pharmacology Biochemistry and Behavior. 67:2000;473-478.
10. Brown R.W., Gonzalez C.L., Whishaw I.Q., Kolb B. Nicotine improvement of Morris water task performance after fimbria-fornix lesion is blocked by mecamylamine. Behavioural Brain Research. 119:2001;185-192.
11. Decker M.W., Majchrzak M.J., Anderson D.J. Effects of nicotine on spatial memory deficits in rats with septal-lesions. Brain Research. 572:1992;281-285.
12. Decker M.W., Majchrzak M.J., Arneric S.P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacology Biochemistry and Behavior. 45:1993;571-576.
13. Fanselow M.S., Kim J.J. Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D, L-2-amino-5-phosphonovaleric acid to the basolateral amygdala. Behavioral Neuroscience. 108:1994;210-212.
14. Fisher J.L., Dani J.A. Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component. Neuropharmacology. 39:2000;2756-2769.
15. Freund R.K., Jungschaffer D.A., Collins A.C., Wehner J.M. Evidence for modulation of GABAergic neurotransmission by nicotine. Brain Research. 453:1988;215-220.
16. Freund R.K., Luntz-Leybman V., Collins A.C. Nicotine interferes with GABA-mediated inhibitory processes in mouse hippocampus. Brain Research. 527:1990;286-291.
17. Fudala P.J., Iwamoto E.T. Conditioned aversion after delay place conditioning with nicotine. Psychopharmacology. 92:1987;376-381.
18. Fujii S., Ji Z., Sumikawa K. Inactivation of α7 ACh receptors and activation of non-α7 ACh receptors both contribute to long term potentiation induction in the hippocampal CA1 region. Neuroscience Letters. 286:2000;134-138.
19. Fujii S., Jia Y., Yang A., Sumikawa K. Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region. Brain Research. 863:2000;259-265.
20. Fujii S., Sumikawa K. Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus. Brain Research. 894:2001;347-353.
21. Fujii S., Sumikawa K. Nicotine accelerates reversal of long-term potentiation and enhances long-term depression in the rat hippocampal CA1 region. Brain Research. 894:2001;340-346.
22. Gilliam D.M., Schlesinger K. Nicotine-produced relearning deficit in C57BL/6J and DBA/2J mice. Psychopharmacology (Berl.). 86:1985;291-295.
23. Gould, T. J. (2003). Nicotine produces a within subject enhancement of contextual fear conditioning in C57BL/6 mice independent of sex. Integrative Physiological & Behavioral Science, 3.
24. Gould T.J., Collins A.C., Wehner J.M. Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition. Nicotine & Tobacco Research. 3:2001;17-24.
25. Gould T.J., Rowe W.B., Heman K.L., Mesches M.H., Young D.A., Rose G.M., Bickford P.C. Effects of hippocampal lesions on patterned motor learning in the rat. Brain Research Bulletin. 58:2002;581-586.
26. Gould T.J., Wehner J.M. Nicotine enhancement of contextual fear conditioning. Behavioural Brain Research. 102:1999;31-39.
27. 3H]dopamine release from synaptosomes prepared from mouse striatum. Journal of Neurochemistry. 59:1992;848-856.
28. Gray J.A., Mitchell S.N., Joseph M.H., Grigoryan G.A., Dawe S., Hodges H. Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Development Research. 31:1994;3-17.
29. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
30. Grigoryan G., Hodges H., Mitchell S., Sinden J.D., Gray J.A. 6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: Effects of nicotine administration on learning and memory in the water maze. Neurobiology of Learning and Memory. 65:1996;135-153.
31. Grilly D.M., Simon B.B., Levin E.D. Nicotine enhances stimulus detection performance of middle- and old-aged rats: A longitudinal study. Pharmacology Biochemisty and Behavior. 65:2000;665-670.
32. Grottick A.J., Higgins G.A. Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behavioural Brain Research. 117:2000;197-208.
33. Hasselmo M.E., Wyble B.P., Wallenstein G.V. Encoding and retrieval of episodic memories: Role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus. 6:1996;693-708.
34. He J., Deng C.Y., Chen R.Z., Zhu X.N., Yu J.P. Long-term potentiation induced by nicotine in CA1 region of hippocampal slice is Ca(2+)-dependent. Acta Pharmacologica Sinica. 21:2000;429-432.
35. Hellstrom-Lindahl E., Mousavi M., Zhang X., Ravid R., Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain. Brain Research. Molecular Brain Research. 66:1999;94-103.
36. Hoehn-Saric R., McLeod D.R., Glowa J.R. The effects of NMDA receptor blockade on the acquisition of a conditioned emotional response. Biological Psychiatry. 30:1991;170-176.
37. Horan B., Smith M., Gardner E.L., Lepore M., Ashby C.R. Jr. (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse. 26:1997;93-94.
38. Jones G.M.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention, information-processing and short-term-memory in Alzheimer's-disease. Psychopharmacology. 108:1992;485-494.
39. Jorenby D.E., Steinpreis R.E., Sherman J.E., Baker T.B. Aversion instead of preference learning indicated by nicotine place conditioning in rats. Psychopharmacology. 101:1990;533-538.
40. Kelton M.C., Kahn H.J., Conrath C.L., Newhouse P.A. The effects of nicotine on Parkinson's disease. Brain and Cognition. 43:2000;274-282.
41. Kim J.J., DeCola J.P., Landeira-Fernandez J., Fanselow M.S. N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behavioral Neuroscience. 105:1991;126-133.
42. Kim J.J., Fanselow M.S., DeCola J.P., Landeira-Fernandez J. Selective impairment of long-term but not short-term conditional fear by the N-methyl-D-aspartate antagonist APV. Behavioral Neuroscience. 106:1992;591-596.
43. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
44. Levin E.D. Chronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat. Pharmacology Biochemistry and Behavior. 58:1997;899-902.
45. Levin E.D., Bradley A., Addy N., Sigurani N. Hippocampal α7 and α4 β2 nicotinic receptors and working memory. Neuroscience. 109:2002;757-765.
46. Levin E.D., Conners C.K., Silva D., Hinton S.C., Meck W.H., March J., Rose J.E. Transdermal nicotine effects on attention. Psychopharmacology. 140:1998;135-141.
47. Levin E.D., Rose J.E. Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Research Bulletin. 27:1991;125-128.
48. Levin E.D., Torry D. Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology. 123:1996;88-97.
49. Logue S.F., Paylor R., Wehner J.M. Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behavioral Neuroscience. 111:1997;104-113.
50. Lynch G., Kessler M., Arai A., Larson J. The nature and causes of hippocampal long-term potentiation. Progress in Brain Research. 83:1990;233-250.
51. Malkani S., Rosen J.B. N-Methyl-D-aspartate receptor antagonism blocks contextual fear conditioning and differentially regulates early growth response-1 messenger RNA expression in the amygdala: Implications for a functional amygdaloid circuit of fear. Neuroscience. 102:2001;853-861.
52. Maren S., Aharonov G., Stote D.L., Fanselow M.S. N-Methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats. Behavioral Neuroscience. 110:1996;1365-1374.
53. Marks M.J., Romm E., Campbell S.M., Collins A.C. Variation of nicotinic binding sites among inbred strains. Pharmacology Biochemistry and Behavior. 33:1989;679-689.
54. McGehee D.S., Role L.W. Neurobiology: Memories of nicotine. Nature. 383:1996;670-671.
55. McIntyre, C. K., Marriott, L. K., & Gold, P. E. (2003). Patterns of brain acetylcholine release predict individual differences in preferred learning strategies in rats. Neurobiology of Learning and Memory, 79, 177-183.
56. Meguro K., Yamaguchi S., Arai H., Nakagawa T., Doi C., Yamada M., Ikarashi Y., Maruyama Y., Sasaki H. Nicotine improves cognitive disturbance in senescence-accelerated mice. Pharmacology Biochemistry and Behavior. 49:1994;769-772.
57. Mirza N.R., Stolerman I.P. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology. 138:1998;266-274.
58. Nelsen J.M., Goldstein L. Improvement of performance on an attention task with chronic nicotine treatment in rats. Psychopharmacology. 26:1972;347-360.
59. Newhouse P.A., Kelton M. Nicotinic systems in central nervous systems disease: Degenerative disorders and beyond. Pharmaceutica Acta Helvetiae. 74:2000;91-101.
60. Newhouse P.A., Potter A., Kelton M., Corwin J. Nicotinic treatment of Alzheimer's disease. Biological Psychiatry. 49:2001;268-278.
61. Newhouse P.A., Potter A., Levin E.D. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging. 11:1997;206-228.
62. Nicoll R.A., Malenka R.C. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Annals of the New York Academy of Sciences. 868:1999;515-525.
63. O'Keefe J.A., Nadel L. The hippocampus as a cognitive map. 1978;Oxford University Press, Oxford, England.
64. Overton D.A. Historical context of state dependent learning and discriminative drug effects. Behavioral Pharmacology. 2:1991;253-264.
65. Paylor R., Tracy R., Wehner J.M., Rudy J.W. DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning. Behavioral Neuroscience. 108:1994;810-817.
66. Peeke S.C., Peeke H.V. Attention, memory, and cigarette smoking. Psychopharmacology. 84:1984;205-216.
67. Perry E.K., Morris C.M., Court J.A., Cheng A., Fairbairn A.F., McKeith I.G., Irving D., Brown A., Perry R.H. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience. 64:1995;385-395.
68. Petersen D.R., Norris K.J., Thompson J.A. A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metabolism and Disposition. 12:1984;725-731.
69. Phillips R.G., Ledoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioral Neuroscience. 106:1992;274-285.
70. Phillips R.G., Ledoux J.E. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learning & Memory. 1:1994;34-44.
71. Radcliffe K.A., Dani J.A. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. Journal of Neuroscience. 18:1998;7075-7083.
72. Riekkinen M., Riekkinen P. Jr. Nicotine and D-cycloserine enhance acquisition of water maze spatial navigation in aged rats. Neuroreport. 8:1997;699-703.
73. Risinger F.O., Oakes R.A. Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacology Biochemistry and Behavior. 51:1995;457-461.
74. Rudy J.W. Contextual conditioning and auditory cue conditioning dissociate during development. Behavioral Neuroscience. 107:1993;887-891.
75. Rusted J.M., Warburton D.M. Facilitation of memory by post-trial administration of nicotine - evidence for attentional explanation. Psychopharmacology. 108:1992;452-455.
76. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information-procession, and short-term-memory in patients with dementia of the Alzheimer type. British Journal of Psychiatry. 154:1989;797-800.
77. Sershen H., Balla A., Lajtha A., Vizi E.S. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience. 77:1997;121-130.
78. Socci D.J., Sanberg P.R., Arendash G.W. Nicotine enhances Morris water maze performance of young and aged rats. Neurobiology of Aging. 16:1995;857-860.
79. Solomon P.R., Solomon S.D., Schaaf E.V., Perry H.E. Altered activity in the hippocampus is more detrimental to classical conditioning than removing the structure. Science. 220:1983;329-331.
80. Stolerman I.P., Mirza N.R., Hahn B., Shoaib M. Nicotine in an animal model of attention. European Journal of Pharmacology. 393:2000;147-154.
81. Warburton D.M., Wesnes K., Shergold K., James M. Facilitation of learning and state dependency with nicotine. Psychopharmacology (Berl.). 89:1986;55-59.
82. Weisskopf M.G., Nicoll R.A. Presynaptic changes during mossy fibre LTP revealed by NMDA receptor-mediated synaptic responses. Nature. 376:1995;256-259.
83. Woodruff-Pak D.S., Li Y.T., Kazmi A., Kem W.R. Nicotinic cholinergic system involvement in eyeblink classical conditioning in rabbits. Behavioral Neuroscience. 108:1994;486-493.
84. Woodruff-Pak D.S., Li Y.T., Kem W.R. A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Research. 645:1994;309-317.
85. Young S.L., Bohenek D.L., Fanselow M.S. NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: Immunization against amnesia by context preexposure. Behavioral Neuroscience. 108:1994;19-29.
86. Zarrindast M.R., Faraji N., Rostami P., Sahraei H., Ghoshouni H. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice. Pharmacology Biochemistry and Behavior. 74:2003;363-369.